Actavis plc, a leading global specialty pharmaceutical company, and Medicines360, a nonprofit women’s health pharmaceutical company, have announced the approval of LILETTA (levonorgestrel-releasing… …read more
Actavis plc, a leading global specialty pharmaceutical company, and Medicines360, a nonprofit women’s health pharmaceutical company, have announced the approval of LILETTA (levonorgestrel-releasing… …read more